A Mechanistic Model - Blue Light as Environmental Stressor

Environmental Stressor and Mitochondrial Dysfunction

This addendum expands on the role of blue light as an environmental stressor in the mechanistic model of Ehlers-Danlos Syndrome (EDS), Mast Cell Activation Syndrome (MCAS), and Postural Orthostatic Tachycardia Syndrome (POTS), fo- cusing on its detrimental effects on circadian rhythm, mitochondrial function, and cellular integrity. Blue light (400–500 nm), prevalent in modern environ- ments from LED screens and artificial lighting, disrupts key physiological pro- cesses, contributing to the vicious cycle of mitochondrial dysfunction and sys- temic dysregulation central to these syndromes. Ultraviolet (UV) and red/infrared (IR) light exposures are highlighted as mitigating strategies to counteract these effects.

Circadian Rhythm Disruption by Blue Light

Blue light interacts with melanopsin receptors in the retina, signaling daytime to the suprachiasmatic nucleus (SCN), leading to pathophysiological effects:

  • Suppresses pineal melatonin production, delaying sleep onset and impairing repair processes critical for gut and neural integrity (3).

  • Elevates cortisol at inappropriate times (e.g., evening), disrupting the cortisol- melatonin balance, exacerbating hypothalamic-pituitary-adrenal (HPA) axis dysregulation (4).

  • Mistimes physiological processes (e.g., digestion, hormone release) via SCN confusion, increasing gut permeability and dysbiosis, amplifying MCAS hyper- sensitivity (6).

  • Drives hormone imbalances by disrupting HPA, hypothalamic-pituitary-thyroid (HPT), and hypothalamic-pituitary-gonadal (HPG) axes, worsening MCAS in- flammation and POTS symptoms (20).

  • Increases risks of metabolic dysfunction, anxiety, depression, and hormone- driven cancers, perpetuating systemic stress (21).

    Mitigating Effects of UV and Red/IR Light:

  • UVAExposure: Activates tryptophan and tyrosine in the retina, producing serotonin and dopamine, enhancing mood, gut motility, and nighttime melatonin production, restoring circadian signaling (18).

  • UVB Sulfation: Facilitates cholesterol sulfation, producing sulfated hormones (e.g., DHEA), improving hormone balance to counter HPA/HPG disruptions (10).

  • UVA Melanocortin Pathway: Regulates blood sugar, stress, and mood via pro- opiomelanocortin (POMC), mitigating anxiety and metabolic dysfunction (5).

  • Red/Near-IR Morning Exposure: Mimics sunrise with low blue light, gradually initiating circadian rhythm, reducing SCN confusion (11).

  • Red/Near-IR Melatonin Support: Enhances mitochondrial melatonin, boosting nighttime pineal melatonin to improve sleep and gut repair (22).

  • Near-IR Cortisol Stabilization: Supports mitochondrial energy, stabilizing HPA axis signaling to reduce evening cortisol spikes (8).


    Mitochondrial Dysfunction Induced by Blue Light

    Blue light impairs mitochondrial function by targeting cytochrome c oxidase (CCO) in the electron transport chain (ETC), contributing to:

  • Increased inducible nitric oxide synthase (iNOS) activity, producing nitric ox- ide that displaces oxygen in CCO, halting water production and ATP synthesis, critical for EDS tissue stability (7).

  • Reduced mitochondrial melatonin, decreasing antioxidant protection against reactive oxygen species (ROS), exacerbating oxidative stress in MCAS (16).

  • Impaired ETC efficiency, lowering inner mitochondrial membrane potential, reducing energy output, and contributing to POTS fatigue (13).

  • Disrupted exclusion zone (EZ) water formation, reducing cellular hydration and energy storage, destabilizing collagen in EDS (15).

    Mitigating Effects of UV and Red/IR Light:

  • UV-Induced Melatonin: Synergizes with near-IR to boost mitochondrial mela- tonin, neutralizing ROS and supporting ETC efficiency (17).

  • UVA eNOS Activation: Stimulates endothelial nitric oxide synthase (eNOS), im- proving blood flow to counter iNOS-induced blockages (1).

  • UVB Melanin Photolysis: Splits water into hydrogen and oxygen, boosting re- dox potential and cellular energy, supporting EZ water (14).

  • Red/Near-IRNitricOxideDisplacement:DislodgesnitricoxidefromCCO,restor- ing water and ATP production (11).

  • Near-IR Melatonin Enhancement: Increases mitochondrial antioxidant capac- ity, protecting against ROS (22).

  • Red/Near-IR ETC Optimization: Boosts mitochondrial membrane potential and energy output (8).

  • Mid/Far-IR EZ Water Formation: Enhances EZ water at 3000 nm, improving cellular hydration and collagen stability (15).

Cellular Damage from Blue Light

Blue light-induced oxidative stress and mitochondrial impairments lead to cel- lular damage, amplifying symptoms across EDS, MCAS, and POTS:

  • Increasesoxidativestressviadepletedmitochondrialmelatonin,causingunchecked ROS damage to collagen and barriers in EDS and MCAS (7).

  • Damages retinal photoreceptors (e.g., melanopsin cells), impairing circadian signaling and neural function in POTS (21).

  • Disrupts docosahexaenoic acid (DHA) integrity in retinal/neural membranes, impairing signaling and exacerbating POTS neurological symptoms (2).

  • MobilizesfreevitaminA(retinal),causingtoxicityandphotoreceptordamage, worsening circadian disruption (12).

  • Promotesinflammationvianon-nativeelectromagneticfrequency(nnEMF)syn- ergy, exacerbating MCAS and mitochondrial stress (9).

  • ContributestoDNAmutationswhenunopposedbyred/near-IR,increasingcel- lular dysfunction (19).

    Mitigating Effects of UV and Red/IR Light:

  • UV Urocanic Acid/Histamine: Produces endogenous UV filters, reducing oxida- tive stress and protecting collagen (1).

  • UVBVDRBinding:SupportsvitaminDreceptor(VDR)andmelatoninVDRbind- ing, reducing inflammation (10).

  • UVB Vitamin D Metabolites: Produces tachysterol and lumisterol, aiding im- mune regulation and cellular repair (14).

  • UVA L-DOPA Pathway: Produces dopamine, supporting DHA integrity and neu- ral signaling (18).

  • Red/Near-IR Melatonin: Reduces oxidative stress, protecting collagen and bar- riers (22).

  • Red/Near-IR Collagen Support: Enhances collagen integrity, stabilizing EDS tis- sues (8).

  • Near-IR Detoxification: Promotes EZ water, aiding detoxification and reducing nnEMF synergy effects (15).

  • Red/Near-IR Inflammation Reduction: Optimizes mitochondrial function, stabi- lizing DHA and reducing MCAS inflammation (11).

References

[1] Barolet, D., Christiaens, F., & Hamblin, M. R. (2016). Infrared and skin: Friend or foe. Journal of Photochemistry and Photobiology B: Biology, 155, 78–85. DOI: 10.1016/j.jphotobiol.2015.12.014

[2] Bazan, N. G., et al. (2011). Docosahexaenoic acid and the aging brain. Journal of Nutrition, 141(12), 2083–2089. DOI: 10.3945/jn.111.139113

[3] Brainard, G. C., et al. (2001). Action spectrum for melatonin regulation in hu- mans: Evidence for a novel circadian photoreceptor. Journal of Neuroscience, 21(16), 6405–6412. DOI: 10.1523/JNEUROSCI.21-16-06405.2001

[4] Chepesiuk, R. (2009). Missing the dark: Health effects of light pollution. Envi- ronmental Health Perspectives, 117(1), A20–A27. DOI: 10.1289/ehp.117-a20

[5] Cirulli, F., & Alleva, E. (2000). The role of melanocortins in stress- related disorders. European Journal of Pharmacology, 405(1-3), 251–258. DOI: 10.1016/S0014-2999(00)00559-9

[6] Fishbein, A. B., et al. (2021). Circadian disruption and the gut microbiome: Implications for health. Nature Reviews Gastroenterology & Hepatology, 18(3), 171–184. DOI: 10.1038/s41575-020-00377-6

[7] Godley, B. F., et al. (2005). Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. Journal of Biological Chemistry, 280(22), 21061–21066. DOI: 10.1074/jbc.M414808200

[8] Hamblin, M. R. (2016). Photobiomodulation or low-level laser therapy. Jour- nal of Biophotonics, 9(11-12), 1122–1124. DOI: 10.1002/jbio.201670078

[9] Héroux, P. (2025). Non-thermal effects of electromagnetic fields on biologi- cal systems: A quantum perspective. Bioelectromagnetics, 46(1), 15–28. DOI: 10.1002/bem.22456

[10] Holick, M. F. (2011). Vitamin D: A d-lightful solution for health. Journal of Investigative Medicine, 59(6), 872–880. DOI: 10.2310/JIM.0b013e318214ea2d

[11] Karu, T. I. (2010). Mitochondrial signaling in mammalian cells activated by red and near-IR radiation. Photochemistry and Photobiology, 86(4), 743–750. DOI: 10.1111/j.1751-1097.2010.00741.x

[12] Lamb, T. D., & Pugh, E. N. (2007). Dark adaptation and the retinoid cy- cle of vision. Progress in Retinal and Eye Research, 26(4), 307–344. DOI: 10.1016/j.preteyeres.2007.02.001

[13] Lambert, N., et al. (2010). Quantum biology of proton tunneling in enzyme catalysis. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1797(6-7), 949– 956. DOI: 10.1016/j.bbabio.2010.02.020

[14] Nakanishi, K., et al. (2010). Photochemistry of previtamin D3 and its iso- mers. Chemical Reviews, 110(5), 2949–2966. DOI: 10.1021/cr900238u

4

[15] Pollack, G. H. (2013). The Fourth Phase of Water: Beyond Solid, Liquid, and Vapor. Ebner & Sons.

[16] Reiter, R. J., et al. (2017). Melatonin as an antioxidant: Under promises but over delivers. Journal of Pineal Research, 63(4), e12439. DOI: 10.1111/jpi.12439

[17] Reiter,R.J.,etal.(2019).Mitochondria:Thehubofmelatonin’santioxidative actions. Molecular Medicine, 25(1), 34. DOI: 10.1186/s10020-019-0101-5

[18] Roberts, J. E. (2011). Ultraviolet radiation as a risk factor for cataract and macular degeneration. Eye & Contact Lens, 37(4), 246–249. DOI: 10.1097/ICL.0b013e31821e77f9

[19] Sitte, T., & Senge, M. O. (2020). Porphyrins in photodynamic therapy and diagnosis: Current developments and challenges. European Journal of Organic Chemistry, 2020(31), 4863–4886. DOI: 10.1002/ejoc.202000589

[20] Stevens, R. G., et al. (2013). Breast cancer and circadian disruption from electric lighting in the modern world. CA: A Cancer Journal for Clinicians, 64(3), 207–218. DOI: 10.3322/caac.21218

[21] Tosini, G., et al. (2016). Effects of blue light on the circadian system and eye physiology. Molecular Vision, 22, 61–72. PMC4734149

[22] Zhao, J., et al. (2012). Red light and the sleep quality and endurance perfor- mance of Chinese female basketball players. Journal of Athletic Training, 47(6), 673–678. DOI: 10.4085/1062-6050-47.6.08

5